MAA
SAGE

Managed Account Advisors’s Sage Therapeutics SAGE Stock Holding History

Managed Account Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$2.9M Buy
39,718
+28,903
+267% +$1.86M ﹤0.01% 1686
2015
Q1 		$543K Buy
10,815
+10,218
+1,712% +$439K ﹤0.01% 2254
2014
Q4 		$22K Buy
597
+2
+0.3% +$75 ﹤0.01% 2540
2014
Q3 		$19K Buy
+595
New +$17.2K ﹤0.01% 2541

Other funds holding SAGE

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Managed Account Advisors's SAGE Position: Q2 2015 in Review

Managed Account Advisors increased its Sage Therapeutics (SAGE) stake by 267% in Q2 2015, buying an estimated $1.86M and bringing the position to 39,718 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Managed Account Advisors first reported a position in SAGE in Q3 2014 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold SAGE as of Q2 2015.

  • Managed Account Advisors held 39,718 shares of Sage Therapeutics worth $2.9M as of Q2 2015.
  • Managed Account Advisors bought 28,903 Sage Therapeutics shares in Q2 2015, an estimated $1.86M.
  • Sage Therapeutics made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1686 holding.
  • Managed Account Advisors first reported a position in Sage Therapeutics in Q3 2014 and has held it in 4 quarters since.
  • 123 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.